Ketamine and Magnesium in Post-operative Pain Control in Patients Treated With Opioids

In this randomized control trial, patients' postoperative pain scores will be assessed as
scored by the Numeric Rating Score (NRS) system. Intraoperative and postoperative narcotic
usage, nausea scores and patients' perception of their quality of recovery via the QoR-40
survey will also be assessed.

The use of intraoperative Ketamine and Magnesium is predicted to decrease postoperative pain
in patients on chronic opioid therapy for management of chronic pelvic pain and will overall
improve patients' postoperative experience.

Inclusion Criteria:

1. Subjects undergoing elective laparoscopic gynecologic surgery

2. Patients with chronic pelvic pain defined as pain that has persisted for more than 6
months in duration which is localized to the pelvis, anterior abdominal wall, lower
back or buttocks and has leads to functional disability or medical care1

3. Patients requiring opioids daily for >1 month

4. Consenting adults age 18-80

5. American Society of Anesthesiologists (ASA) Physical Status classification II to ASA
III

Exclusion Criteria:

1. Patient refusal

2. Chronic Kidney disease (Creatinine>2)

3. Patients treated with methadone

4. Known allergy or adverse effect of ketamine or magnesium

5. Patient unable to give informed consent

6. Patient with limited or no English fluency

7. Uncontrolled hypertension